Allegra Generic Launch Prompts Injunction Request
In an escalation of the patent war over Allegra, a partner of Sanofi Aventis has requested an injunction to prevent rivals from making a generic version of the allergy drug prior...To view the full article, register now.
Already a subscriber? Click here to view full article